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No longer raising eyebrows: The contexts and domestication of Botox 
as a mundane medical and cultural artefact  
 
 
Abstract 
Cosmetic enhancement technologies have been subject to extended sociological and 
feminist critique, but botulinum neurotoxins (Botox) have been sidelined in this 
discussion. This has occurred despite Botox’s popularity and accessibility as a 
nonsurgical cosmetic procedure. While Botox shares many similarities with cosmetic 
enhancement technologies such as cosmetic surgery, we argue that the fields and the 
socio-spatial organisation of Botox - where Botox is performed and by whom, which we 
collectively call contextual Botox - not only differentiate it from other cosmetic 
enhancement technologies but expose how Botox has gone beyond normalisation to 
become hypernormalised; a domesticated, mundane technology that has largely 
disappeared into the flows and routines of everyday life. In addition, Botox is a distinct 
medical and social practice that is multifaceted, being determined by the contexts in 
which it is found and the forms of cultural capital therein.  It is for these reasons, in 
addition to being the most popular form of cosmetic enhancement, that Botox should be 
critically scrutinised. 
 
Keywords - Botox; botulinum neurotoxin; cosmetic surgery; cosmetic enhancement 
technologies; body modification; sociology of culture; field; capital; Bourdieu 
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Introduction: BOTOX® to Botox 
 
I dye my hair and I do other things [like Botox], so what? (Anna Bligh, in 
Cogdon, 2009: 35). 
 
I’ve had a bit of Botox, which these days feels like having a facial 
(Rebecca Gibney, in Watson, 2009: 30). 
 
I mean, for me, it’s [Botox] like cleaning my teeth, you know? Something 
makes your teeth whiter or something stops you having lines (Simon 
Cowell, in Jefferies, 2010: 3). 
 
 
These comments, made by a music and television producer (Cowell), an actor (Gibney), 
and former politician (Bligh) represent increasingly common ways of thinking about 
cosmetic forms of botulinum neurotoxin such as Dysport® (also known as Reloxin®) 
and  BOTOX®. These products are becoming socially normalised and, as these quotes 
reveal, equated with other common non-invasive cosmetic products. As a result, 
BOTOX® as a brand-name has become familiar terminology for all cosmetic forms of 
botulinum neurotoxin (Botox), and transcends the subject who administers it; ‘Botox 
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has an agentic presence that appears in the cosmetic surgery world somewhat 
independently of patients, clinics or doctors. It is an artefact in itself’ (Jones 2008: 75). 
By likening Botox to widely available salon treatments and everyday hygiene practices 
considered neither socially controversial nor extreme, Botox is becoming “run-of-the-
mill”. It is moving out of expert offices and clinics of dermatologists and cosmetic 
surgeons, and into beauty salons and hairdressers, speciality Botox-only offices, and 
homes or rented hotel rooms for Botox parties. It is an “on the whim”, impulsive 
consumer product.  
While many people lack the finances to afford Botox, it is more financially 
accessible than the thousands of dollars (and enduring pain) of more invasive cosmetic 
enhancement technologies (CETs) (Reel et al, 2008). Prices for Botox treatment vary 
according to why it is being used, where it is injected, and the consumer’s gender, with 
one dermatologist noting that Botox for frown lines is slightly cheaper for women than 
men (Cogdon, 2009). As Botox is relatively affordable and easily accessible in familiar 
social places, this renders it banal; as mundane as having a haircut or a facial, though at 
slightly more cost. 
To date little research has examined the socio-cultural factors shaping Botox 
use, with greater attention granted to “extreme” CETs of cosmetic/ aesthetic surgery. 
Botox has been overlooked as a comparatively harmless, non-invasive procedure. As 
examined in this article, Botox as a social and medical practice is similar to but also 
substantially different from other CETs, particularly cosmetic surgery. These 
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divergences and the general accessibility of Botox, warrant sociological and feminist 
investigation. 
This article addresses this shortfall by highlighting how Botox is a mundane 
socio-cultural artefact due to its association with other everyday practices and its 
incorporation into familiar environments. The article briefly defines Botox as a product, 
and examines the existing social literature on cosmetic surgery. This research assists 
with thinking through how Botox could be theoretically conceptualised, and reflects the 
shortfall of social research on injectable CETs. Drawing on this existing knowledge, 
press releases from professional organisations, and media reports (including interviews 
with medical professionals), we show that Botox is a similar and different medical and 
cultural artefact to cosmetic surgery. The discussion then demonstrates how Botox is 
distinguishable from other CETs due to the fields and socio-spatial organisations it is 
found in, and the types of knowledges and interactions occurring in these spaces. We 
collectively call this contextual Botox, which broadly relates to where is it performed 
and by whom, and how this relates to knowledge and power. 
We argue the domestication of Botox is evidenced in the movement of Botox 
from medical contexts to everyday environments that serve to decontextualise it, 
increase its everydayness, and mask its potential dangers. Accompanied by the relative 
affordability, procedural ease, and accessibility of Botox, the inherent risks of Botox 
have become separated from it as a medical product and a procedure, making it appear 
harmless and similar to more benign non-invasive, nonsurgical, and familiar cosmetic 
enhancements. This illustrates how Botox has gone beyond normalisation to become 
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hypernormalised, dissolved into the heterogeneity of other readily available body 
maintenance products and technological equipment employed in everyday environments 
to make modern life “easier”. Thus, the medical and cultural meanings of Botox and the 
fields in which it is associated are shifting, and this product becomes fluid in the 
process. As a result, the mundaneness of Botox must be treated seriously. 
 
What is Botox? 
Botox is botulinum neurotoxin. It is produced by the organism clostridium botulinum, 
and is the most poisonous toxin known. By inactivating proteins known as the SNARE 
complex, botulinum neurotoxin causes the muscles to contract and blocks the nerves, 
resulting in paralysis. In diluted forms such as found in Botox, this lasts from three to 
four months at which time nerve endings are repaired (Lipham, 2004; Ting and 
Freiman, 2004). Thus botulinum neurotoxin is a lethal substance, and desirable aesthetic 
and medical product.  
In the 1980s, two dilute strains of botulinum neurotoxin, A and B, became the 
first biological toxins approved to treat human diseases such as hyperactive muscles, 
involuntary muscle contractions, and tremors and spasms in the face, trunk and limbs 
(Ting and Freiman, 2004). During the treatment of strabismus (crossed eyes) and 
blepharospasm (uncontrolled blinking), Canadian ophthalmologist Jean Carruthers and 
her patients discovered a side effect of Botox: it reduced the appearance of frown lines 
(Benedetto, 2003; Ting and Freiman, 2004). Today, diluted forms of botulinum 
neurotoxin wage war against a readily identifiable and despised enemy: wrinkles.
1
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As a medical and aesthetic tool, Botox is used for a range of on-label (approved) 
and off-label (unapproved) treatments. These include excessive sweating, migraines, 
involuntary neck muscle contractions, Parkinson’s disease, cerebral palsy in children, 
multiple sclerosis, anal fissures, various forms of pain, and vocal disorders (Benedetto, 
2003; Klein, 2002; Ting and Freiman, 2004). The primary way Botox has captured the 
public imagination, however, has been its aesthetic uses. For example, in addition to 
treating lines and wrinkles, Botox and other injectables can be used to assist individuals 
to wear stilettos for an entire day (Wilson, 2009) or to tighten sagging cleavage 
(Macrae, 2009). One female journalist has claimed that having Botox and injectable 
fillers  restored her family’s harmony because she looked less grouchy (Castagnoli, 
2013). The markets for Botox are clearly diverse – it has become a “cure all” for a 
variety of health and aesthetic concerns (Benedetto, 2003; Klein, 2002; Nissen, 2006; 
Wunder, 2004), as well as a tool for maintaining peace at home and improving one’s 
work position (Castagnoli, 2013; Hughes, 2012). Botox, therefore, is an investment in 
one’s public and private life, a form of what Holliday and Cairnie (2007) would term 
“body capital”. 
While Botox has captured public imagination, it is still botulinum neurotoxin. 
Botox injections have been fatal in some patients due to Botox travelling from the 
injection site to other areas of the body, including paralysing respiratory muscles 
(Stewart, 2010; U.S. Food and Drug Administration, 2013). Other potential side effects 
include pain, haemorrhage, infection, drooping eyes, flu-like symptoms, drooling, fever, 
nausea, and headaches (Adverse Drug Reactions Advisory Committee, 2009; 
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Mandeville and Rubin, 2004). Despite these issues, Botox use is significant and 
increasing. Since approved by the American Food and Drug Administration (FDA) on 
15
th
 April 2002 for specific cosmetic purposes (Lipham, 2004), Botox has been the top 
nonsurgical cosmetic intervention in the United States. From 2003 to 2013, Botox 
procedures were consistently double that of the second most popular nonsurgical 
cosmetic enhancement (laser hair removal in 2003-2005, 2008, and hyaluronic acid in 
2006-2007, 2009-2013); in 2012 and 2013, consumption outstripped the other top five 
nonsurgical cosmetic enhancements combined; and during 2013, its use more than 
tripled the top five surgical cosmetic procedures combined (see Charts 1 and 2).
2
 These 
figures also underestimate Botox use as they exclude non-member procedures and 
medical tourism (Holliday and Cairnie, 2007). Clearly, Botox use is significantly higher 
than all other CETs.  
Despite these statistics, Botox is yet to be taken seriously as a social and medical 
phenomenon within sociology, cultural studies, or feminist studies. Overlooking this 
practice as worthy of empirical investigation oddly runs alongside an ever increasing 
discussion of CETs as social phenomena by feminist and socio-cultural theorists alike. 
  
[insert Charts 1 and 2 here] 
 
How can we conceptualise Botox in relation to surgical forms of cosmetic 
enhancement technologies? 
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Contrasting with plastic and reconstructive surgical procedures seeking to restore or 
correct bodily function and appearance (for example, for people with severe burns or 
physical disfigurement), we define CETs as nonsurgical and surgical procedures that 
alter, change, or modify the surface, function and appearance of the body purely for 
aesthetic purposes. This includes cosmetic/ aesthetic surgery and non-invasive 
procedures such as chemical peels and laser resurfacing, and injectables such as 
hyaluronic acids and Botox. The most extreme and expensive CETs, cosmetic surgery, 
has been subject to intense interrogation in existing feminist and socio-cultural research.  
One feminist perspective frames CETs as women’s oppression in a Westernised 
patriarchal culture, offering narrow and unrealistic feminine bodily ideals (Hesse-Biber, 
2007). Cosmetic surgery is criticised as “correcting” women’s bodies to better fit with 
ideals of femininity, founded in real and imagined images of youthfulness and beauty. 
This highlights the power imbalance of a wealthy, male, professional surgeon defining 
standards of female attractiveness (Polonijo and Carpiano, 2008), and carving into 
physically healthy women’s bodies for aesthetic purposes due to their perceived social 
deviance (Akass and McCabe, 2007). Through such practices women are victims of 
exploitation (Morgan, 1991), deemed pathological and in need of a “cure” (Blum, 
2007). 
Other feminist accounts challenge the notion that women are cultural “dopes” or 
“puppets” unsuspectingly enrolled into a patriarchal, oppressive feminine bodily 
culture. Research with women who have had cosmetic surgery indicates that they 
undergo these procedures to look “normal”, not like the dominant feminine ideal 
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(Davis, 2003). Women are not tricked by patriarchal culture, but create and shape 
confident, adaptable, and desirable selves (Davis, 1995). They are ‘savvy cultural 
negotiators, attempting to make out as best they can within a culture that limits their 
options’ (Gimlin, 2001: 106).  From this agentic perspective, cosmetic surgery can 
empower and is not just about beauty (Davis, 1995) but, as Gimlin’s (2001) work 
demonstrates, this is only achieved within normative femininities.  
These two approaches have differing perspectives on cosmetic surgery: as 
oppressive, patriarchal, and structural; and as liberatory, empowering, and 
individualistic. Socio-cultural accounts of CETs, however, rethink cosmetically 
enhanced bodies in terms of the social, cultural, and economic factors producing the 
conditions in which cosmetic surgery is made possible and desirable (Elliott, 2008). 
This indicates CETs are used to discursively mark out particular feminine subjectivities 
(Balsamo, 1992), with social discourses about women’s bodies informing physician 
ideas on women’s choices (Parker, 2009) and their own surgical techniques. Thus, client 
and practitioner interpretations of CETs are filtered through wider social constructions 
of women’s bodies and cosmetic surgery that are more complicated and nuanced than 
oppressive or liberatory arguments. In addition, Shapiro (2015: 112) notes: 
 
If they [women] cannot or choose not to engage in these types of 
beautifying body work, they experience social stigma, discrimination and 
marginalization; if they do participate, they risk being viewed as powerless 
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creatures swept asea by dangerous practices they should have been strong 
enough to resist.  
 
It is a no-win scenario. Furthermore, socio-cultural accounts highlight that men are also 
clients of cosmetic surgery, who – like some women – reportedly use it as a form of 
body capital (Holliday and Cairnie 2007).
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While Botox has not been extensively critiqued, we can speculate how each 
perspective may conceptualise this CET. One feminist argument could be mounted 
against Botox because it represents the material practice of women’s oppression and 
their desperation to achieve appropriately gendered bodies that align with dominant 
Western ideals of youthful feminine beauty. Submitting to Botox injections means 
women are complicit in their own oppression and are disempowered. In contrast, a 
differing feminist perspective enables an understanding of how, by “stopping time”, 
Botox may make it possible for women to attain an imagined and historically 
unattainable female body – a confidence inspiring body devoid of wrinkles and makes 
them feel normal. Thus, Botox can offer women “liberation” from the “war against 
ageing”; a future free from worrying about being “traded in” for a younger model by 
their partners or the workplace. Botox can make normal (that is, wrinkle free) female 
bodies that fade into the backlight of everyday gendered normality and remove bodily-
induced angst (Shapiro, 2015). 
In a socio-cultural paradigm, Botox appears broadly as a bodily technology that 
resurfaces the body and is not necessarily analysed from a gender perspective. While the 
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emphasis in socio-cultural accounts is ‘how subjectivity and embodiment are inscribed 
by surgical accounts and practices in the very production of normative and non-
normative bodies’ (Doyle and Roen, 2008: 5), Botox can create muted subjectivities 
that could be situated as deviant (for example, faces that have limited expressive 
capacity or do not emote because they are paralysed); atypical of those normally 
encountered in everyday life. Jones (2012) notes how, although Botox creates mute 
subjectivities, it is also part of a range of injectables creating temporary, mutable, and 
fashionable looks for women. Arguably, Botox is the fashion artefact which now speaks 
for itself, a dynamic in which the physician is even more muted because the reputation 
of Botox precedes clinical knowledges and minutiae processes like informed consent.  
Our examination complements the socio-cultural approach by focusing on how 
Botox is made a medical and cultural artefact through dynamic interactions between 
social, cultural, economic, medical, and political factors. Our approach is influenced by 
Bourdieu’s concept of field; ‘arenas of production, circulation, and appropriation of 
goods, services, knowledge, or status, and the competitive positions held by actors in 
their struggle to accumulate and monopolize these different forms of capital’ (Swartz, 
1997: 117). As such, a field is a social space constituted by specific rules, languages, 
activities, and relations. Each field, however, can include individuals with competing 
interests. Furthermore, a field may have overlapping interests with another field, which 
can bring these into conflict over capital and resources. For example, Botox is an 
artefact that intersects with different fields – political, medical, beauty and domestic – 
that come into competition with each other and are altered by, and alter, the artefact 
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itself. These fields intersecting with Botox create a hierarchy, with divisions and 
struggles for power that connect to inequalities in economic capital (which refers to 
material resources such as wealth and profits), cultural capital (such as skills, 
knowledge and educational credentials), and social capital (networks of connections and 
acquaintances, and memberships to particular groups) (Bourdieu, 1986). 
Our approach goes beyond current understandings of CETs by engaging with 
structural factors – and not patriarchal culture or gender - that operate within differing 
contexts, in conjunction with agents therein, to create Botox as an artefact before it 
reaches the consumer. In other words, our focus is on the complicated structural 
components that interact with, affect, and are influenced by, the field, context, and the 
provider and consumer. Significantly, while injectables like Botox may appear mundane 
in light of the pain and recovery time produced by surgically invasive procedures, they 
should not be sidelined in academic research. It is particularly important to consider 
how the field (such as relations between knowledge and place) creates different forms 
of Botox that construct different relationships between divergent providers, and between 
provider and consumer. So while we acknowledge the varying approaches to CETs, we 
illustrate how Botox is located in broader socio-cultural and socio-spatial frameworks as 
a medical and cultural artefact that marks it as profoundly different to other CETs and 
worthy of theoretical and empirical investigation. 
 
The Domestication of Mundane Botox 
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[…] mundane technology in everyday life constantly shapes humans, and 
humans shape it. It enables and constrains various modes of comportment 
(Michael, 2000: 41). 
 
While cosmetic surgery is arguably becoming increasingly normalised, it can only be 
performed in medical environments. Consultation occurs in a clinic, it is a specialised 
practice, and requires the confidentiality and privacy of doctor-patient relationships. The 
procedure requires general (or sometimes local) anaesthetic, a sterile surgical theatre 
and specialised tools. Recovery occurs in hospital and may continue at home or, as per 
cosmetic surgery tourism, in a luxurious hotel. Cosmetic surgery renders the individual 
a patient in need of medical treatment, supervision, and care. Furthermore cosmetic 
surgery is expensive, making it prohibitive for many. It remains elusive in its location 
and knowledge, and exclusive in its accessibility and affordability. This means that 
despite the normalisation of cosmetic surgery, it remains an exotic technology.  
In contrast, Botox is a mundane technology.
3
 According to Michael (2000: 3), 
mundane technologies are ‘technologies whose novelty has worn off; these are 
technologies that are now fully integrated into, and are an unremarkable part of, 
everyday life’. While Botox still captures the public imagination, it is a mundane 
technology precisely because it is increasingly aligned with other non-invasive CETs 
that are “normal” and do not warrant serious attention. As the quotes in the Introduction 
show, Botox is becoming (or has become) part of beauty regimes that, pardon the pun, 
do not raise eyebrows. It is an additional feature within the self-maintenance routines of 
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everyday life. In other words, it is a mundane technology because it has transcended the 
medical field, entering a number of fields that are not special or endowed with 
specialised and privileged forms of cultural and social capital. 
 This mundaneness of Botox has also been enabled through its domestication, 
which ‘capture[s] the way that new technologies enter everyday life and how, in the 
process, that sphere at once accommodates to, and reconstitutes, those artefacts’ 
(Michael, 2000: 10). This domestication and its increasing mundaneness has been 
facilitated with Botox moving out of medical environments (medical field) and into 
everyday spaces (domestic field), and away from specialists. It is used by registered 
nurses, beauticians, the “person down the road”, and the consumer through do-it-
yourself (DIY) kits and “faux-tox”. 4 These relationships between location, knowledge, 
and availability, which we collectively call contextual Botox, have made Botox more 
accessible and socially acceptable. This has helped to increase its marketability, and 
reconfigure and distinguish Botox as an artefact; located both within the medical field 
(medical artefact), and a more flexible artefact, located and consumed within other 
fields that render it unremarkable (cultural artefact). In the process, Botox as an artefact 
not only reshapes consumers and a diversity of providers, but is also altered by the 
fields and contexts in which it is found. The complicated configurations aligning place, 
people and knowledge, from which Botox cannot be separated, render it a 
heterogeneous entity. This relates to Bourdieu’s concept of field where distinctive 
practices, knowledge, and rules exist in each field (Swartz, 1997), which map to 
different contexts and agents. These distinctions and differences between fields are of 
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interest here. As demonstrated below, this involves battles over Botox – where it can be 
used, by whom, and how – meaning these fields speak of social positions, power 
relationships, economics, and inequality. These complexities distinguish Botox as a 
distinctive CET from cosmetic surgery and, due to its regulation as a medical product 
(political field) and its potentially dangerous and fatal toxicity, from other injectable 
CETs as well. The various locations of Botox and the knowledge associated with these 
differing places, and how this creates the different forms of contextual Botox, are 
outlined in Table 1. 
 
[insert Table 1 here] 
 
Each location in Table 1 is matched with how the product can be conceptualised 
as a medical and cultural artefact, and the relationship to production and circulation of 
knowledge due to its position in place and field. This results in tension between medical 
and broader cultural conceptualisations of Botox. For example, when Botox is 
administrated in surgery or a medical practitioner’s office (first form of contextual 
Botox), it is located in a medical field that ensures the seriousness and control of the 
product as medical is maintained and which, in Bourdieusian terms, strongly aligns 
economic and cultural capital (Bourdieu, 1986). This is because, for example in 
Australia, Botox is a prescription medicine (classified as S4) meaning it can only be 
stored, supplied, and used by a qualified practitioner. It also cannot be directly marketed 
to consumers under the brand name by the manufacturer or provider, but a provider can 
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advertise that they supply “anti-wrinkle treatments” (Therapeutic Goods 
Administration, 2013).
5
 These regulations indicate the seriousness of the product by 
restricting who can have direct access to it, and who (and who not) receives product 
information. This assumes who has the capacity to understand and evaluate knowledge.
6
 
The outcome is the creation of a field of power (Swartz, 1997) (dominance of medical 
authority) that shapes dynamics in the other fields where Botox is located (see Table 1). 
This privilege of social and cultural capital, and the alignment between the medical and 
political fields, legitimises the medical profession’s exclusive access to the economic 
capital associated with Botox. As a result, Botox becomes symbolic of the power 
relations between different fields. 
Medical claims over Botox and its use – a demonstration of cultural capital – are 
witnessed in calls for further regulation. These emphasise a desire to monitor the 
product and its supply, and to ensure authority and control over the product including its 
location, distribution and provision. Botox regulation as a medical product means it 
should be confined and restricted to a particular field and what relates to that field 
(context, knowledge, and so on), which reinforces the privileged control of, and strong 
alignment between, economic and cultural capital for medical professionals. This forms 
Botox as a medical artefact; an identity that, if it holds, would constrain alternate uses 
and understandings, and thus reduce the fields in which Botox can be found and the 
different forms of contextual Botox.  The medical pressures to regulate Botox beyond 
its listing as a prescription medicine, however, are not necessarily successful. This 
allows other fields of Botox to emerge, and new contexts and forms of cultural capital. 
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For example, after a call in 2007 to regulate Botox in the United Kingdom, the 
government ‘backed away’ (Climbdown over Botox regulations, 2007: 1), and 
emphasised consumer responsibility by giving Botox parties ‘the all-clear’ in 2010, 
provided that practitioners displayed ‘a quality mark’ (Smith, 2010: 13) (see Table 1). 
Such politicisation of Botox, whereby it transcends medical control and places a value 
on consumer cultural capital, does not suit the construction of it as only a medical 
artefact located in the medical field, resulting in continual calls to ban Botox parties 
internationally (for example, Doctors call for ban on Botox parties, 2013). Such battles 
are an attempt to ensure Botox is located in the “correct” field; with those high in 
cultural capital. This replicates and reinforces claims made to disciplinary authority 
(Foucault, 1991 in O’Farrell, 2005).  
There is little doubt Botox is invested with potential harms in such calls for 
heightened regulation, yet there is little consistency. This is evidenced by the 
dislocation of Botox from traditional medical environments and practices (our third and 
fourth forms of contextual Botox), which challenges medical dominance and control. 
This demonstrates how the fields in which Botox is found come into conflict. It is 
important to note, however, that such reconceptualisations emerge from inside and 
outside of the medical field. For example, as previously indicated, the politicisation of 
Botox through regulation directs who can have access to it and where it can be 
administered, facilitating its emergence in new fields and places. Significantly, the 
regulations (political field) do not mean that only a registered medical doctor can 
perform Botox injections. This highlights how fields with an interest in Botox overlap. 
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Here, there is a tension between who can prescribe and who can inject Botox. In 
Australia, a qualified nurse can inject a client with Botox under a medical doctor’s 
supervision “at a distance”, meaning the medical doctor does not need to be physically 
present or available on-site as long as they can be contacted and written consent for the 
injections has been provided (Australasian Society of Cosmetic Medicine, 2005). This 
allows Botox to emerge in non-medical contexts such as beauty salons, as long as the 
regulations are followed. In this process, locating Botox in the medical field changes 
and is challenged - medical authority is maintained in its expertise over the body due to 
regulatory requirements (cultural capital), while taking advantage of expanding markets 
and contexts for Botox (economic capital). Simultaneously, there is a desire to retain 
medical power over Botox, and thus maintain the privilege of control over how place, 
people, and knowledge are interlinked. Movements of this injectable outside of medical 
contexts, however, exposes conflicts of interest related to regulation, product control, 
and disciplinary authority. This aids to reconfigure the hierarchical relationship between 
provider and consumer, and increase economic capital through new fields and 
entrepreneurialism. These slippages mean that sustaining a strong identity for Botox as 
a medical artefact restricted to the medical field becomes challenging:  
 
Botox should not be done in a spa where you don’t always know exactly 
who is injecting you and where it is presented in the same context as a hot 
stone massage or a facial scrub. Nor should it be done in someone’s house 
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where the doctor can’t control the cleanliness or the lighting (Dr Elkwood, 
plastic and reconstructive surgeon, in Singer, 2007: G.3). 
 
In the case of Elkwood (above), this suggests that it is the expertise (cultural 
capital) linked with context that marks the safety of Botox. This movement also allows 
medical professionals to take advantage of economic capital linked with Botox’s 
popularity. Thus, in line with Foucault’s (1991) disciplinary power, there is a desire to 
control place and what occurs in that place (in O’Farrell, 2005). At the time of this 
comment, Elkwood was opening a “drop-in” Botox-only clinic in New York, but this is 
constructed as a controlled environment because of his presence as a specialist to 
manage and administer injections (our second form of contextual Botox): ‘Botox has 
become mainstream and this [Botox-only clinic] is the next step in its evolution’ 
(Elkwood, in Prior, 2007: 6). Thus, location itself does not determine if Botox is out of 
place, but rather whether the site is directly and physically regulated (or embodied) by 
medical knowledge and practitioners (that is, located within the medical field). 
Consequently while generating economic capital is important, cultural capital 
(knowledges and practices) varies in the different fields in which Botox is located. The 
further these two poles – economic and cultural – are apart, the more distant Botox is 
from medical control. As a result, medical associations with vested interests mobilise 
their social capital and seek to claim Botox by creating their own political field around 
it. For example Dr Caswell, from the Cosmetic Physicians Society of Australasia 
(CPSA) (in Cogdon, 2009: 36), indicates that qualified nurses working “at a distance” is 
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‘a totally inappropriate bending of the rules’. In addition, the CPSA (2009b) released its 
own protocols and practice guidelines on how members should apply the Australian 
national regulations; an attempt to enforce social capital and impose their own symbolic 
ordering. The existing regulations (political field) are constructed as insufficient and 
disciplinary expertise (cultural capital) is asserted in an attempt to reclaim authority. As 
the dominant field with high amounts of economic, cultural and social capital, effort is 
invested in asserting and strengthening the rules. The outcome is Botox is confirmed as 
a medical artefact.  
The cultural demand for and financial benefits from Botox have altered how 
medical contexts are designed and located in social space. The contexts of Botox 
reconfigure the medical field (our first and second forms of contextual Botox), and alter 
Botox as an artefact. For example, the movement of specialists to contexts outside of 
traditional medical environments – our second form of contextual Botox – indicates 
Botox’s attractiveness as economic capital to medical practitioners, but this also helps 
promote the decontextualisation of Botox through the alterations of place and an 
increasing normalisation. By placing Botox clinics in mainstream, convenient 
environments, Botox becomes highly accessible and is not differentiated from other 
consumable beauty products found widely in such locations. Therefore, while Botox-
only clinics are differentiated from beauty spas (our third form of contextual Botox) in 
theory, the shop-front location makes them hard to separate in practice and within the 
social imagination. This is because elements of these different fields overlap, resulting 
in the social distancing of the product from being a regulated pharmaceutical. It is a 
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quick fix: ‘People just need to be educated that it’s fast, it’s cheap, and it’s not 
intimidating’ (Dr Rose, plastic and reconstructive surgeon, in Singer, 2007: G.3). The 
medical desire to economically benefit from Botox means the movement to non-clinical 
contexts challenges the authority that medical experts also seek to claim over Botox. 
They weaken their social capital and, potentially, their cultural capital. Such changes, 
however, may experience resistance (the CPSA) and acceptance (Elkwood and Rose) 
from within the medical field, yet are both reactions to the same pressures exerted from 
external (political) and less dominant (beauty and domestic) fields, while also revealing 
the relationship between Botox and economic capital. 
Elkwood’s quote also connects to the fourth form of contextual Botox indicated 
earlier – Botox at home and Botox parties (domestic field). These developments 
highlight the (mass) commercialisation of the product (Mandeville and Rubin, 2004), its 
capturing of the public’s imagination, the possibly lucrative entrepreneurial potentials 
(economic capital), and the exploitation of social fears of ageing. This process 
hypernormalises Botox by removing all medical contexts and knowledges associated 
with the procedure and the product, thus removing claims to disciplinary power and 
control, and making it socially familiar and everyday. The field has shifted from 
medical to domestic, which lessens the strength of cultural capital.  
Botox parties involve groups of clients who socially gather and receive Botox 
injections.  These may occur in a clinic, but also in beauty salons, hotels, and people’s 
private homes.  It might have a dress-up theme such as Halloween, Boot Camp, or a 
nursery rhyme (Clough, 2007). These practices imply Botox is playful, worth 
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celebrating, superficial like a costume, and even frivolous because it is less hideous than 
what it allegedly prevents: vile wrinkles. For organisations like the American Society 
for Aesthetic Plastic Surgery (ASAPS) (2008), Botox parties are fraught with potential 
dangers. Again, however, the call of Botox as economic capital and cultural artefact can 
lure medical specialists outside their traditional contexts, as well as entice illegal Botox 
markets.  For example, Shearer Palmer (2004: 13a) reports that: 
 
As I waited for a routine skin check at my dermatologist’s office, a flyer 
caught my eye. My doctor was offering a special: If a patient organized a 
Botox party with six or more guests, he would give the organizer free 
Botox injections and bring complimentary hors d’oeuvres to the party.  
 
Free perks for hosting parties reflect Tupperware or Avon parties – the difference 
here is the free perk is poison and a regulated pharmaceutical. The shifting of the 
product outside of a regulated environment creates new contexts and fields that, in turn, 
influence how the product is conceptualised. Specials and deals offered through Botox 
parties mask those factors associated with the medical field (seriousness of the 
procedure) and the political field (regulation of the product) - it has become a cultural 
artefact in the domestic field, just another marketplace product offered as a “bonus” or 
“today’s special”.  Similarly the celebratory aspect of Botox parties, emphasising fun, 
getting together and social solidarity, may compromise voluntary and informed 
participation:  
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In this atmosphere of ‘Botox parties’ where champagne-sipping socialites 
are injected with botulinum toxin, it is easy to forget that botulinum toxin 
is a potent neurotoxin and that its very long term effects are still unknown 
(Dr Misra, neurophysiologist, in Simpson, 2013: 1). 
 
While this quote somewhat denigrates Botox users, Misra nevertheless highlights 
the medical uncertainties surrounding this product are heightened when removed from 
the medical field. This occurs not because of Botox as a product, but due to the 
administrative context. That is, Botox remains a toxin and will always remain so 
regardless of the context, but its toxicity is emphasised by medical professionals once it 
shifts from the medical field. This means Botox is constructed as a regulated and safe 
product when located in contexts with “appropriate” social and cultural capital (Botox 
as a medical artefact), but its identity as botulinum neurotoxin becomes exposed and 
discussed by disciplinary experts once it is located “elsewhere”; outside of their field 
and their social and cultural capital (Botox as a cultural artefact). Consequently, the 
risks associated with Botox are contextually constructed, related to fields, locations, and 
places rather than connected with the product itself.  
At a Botox party, according to the medical field, providers need to ensure they 
have explained the risks, benefits, and possible alternatives, and that clients have 
understood this information, raised their concerns, and made an informed decision. It 
can be questioned whether this is possible in the collective, non-threatening 
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environment of a Botox party. The location of Botox in a different (domestic) field 
means that injections become a symbol of group belonging and solidarity, as opposed to 
an individual, private intervention. They enable, reinforce and create social capital by 
bringing people together who all have an interest in Botox, and are likely to be 
considering it for their aesthetic concerns.  
This decontextualisation and decentralisation of Botox means the medical field no 
longer holds control over the product, and their knowledges become irrelevant. While it 
could be argued this empowers the consumer to assert their needs outside of the 
patriarchal institution (and field) of medicine, this is only achieved through significant 
risks. The procedural confidentiality for the consumer and the provider’s ability to 
‘cautiously direct the patient at obtaining emotional and psychological help’ when they 
have unreasonable expectations of Botox (Benedetto, 2003: 466), are compromised at 
best.  Even if there is a “Botox room” separate from the primary party environment, it 
will be immediately evident if the procedure has been done: Are there drops of blood? 
Is any swelling or redness evident? Is frowning possible? Did you have it? The “other 
room” cannot provide privacy in a peer communal environment – Botox occurs in a 
public domain where it is openly shared and discussed, and everyone knows what you 
have had done. In this case, the emotionless face is not a “poker face”, as the reduced 
capacity for expression reveals all. This hypernormalisation of Botox through its 
domestication exposes the distancing of Botox from being a medical artefact and its 
reconstitution as a cultural artefact, and the fields shifting from medical to domestic. 
The contexts and provider-consumer relationship radically change. 
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As seen by our fourth form of contextual Botox, the decontextualisation and 
dislocation of Botox from medical product to aesthetic product, and the movement from 
medical specialisation to everyday practice, takes normalisation to new levels 
unattainable by cosmetic surgery. Botox has been hypernormalised. This is perhaps best 
illustrated by the availability of faux-tox and DIY Botox kits, the latter which are 
available via the Internet and have previously sold on eBay (Poulter, 2009). Videos can 
also be found on YouTube showing and instructing users on how to prepare and insert 
Botox (see https://www.youtube.com/watch?v=TWEPgoDBPw0). Here, Botox is 
decentralised from the medical in terms of context, knowledge, and delivery, and 
recontextualised in the domestic field, with medical contexts and knowledges 
completely removed. Potential dangers become obscured behind an image of an 
everyday beauty product.  The complete distancing of Botox from medicalisation thus 
renders the origins of this substance invisible, and the regulations from the political 
field silenced. At the same time, Botox parties reconfigure the power dynamic between 
provider and consumer in ways not possible by CETs that require anaesthetic, as the 
exclusive control medical professionals have over this product and its profits are 
challenged. The consumer becomes empowered to assert control – to some extent – over 
their own body modification practices and contexts.  To reassert their fields of power, 
clinicians therefore highlight how recontextualisation is problematic:  
 
It’s become socially acceptable to buy online, but it’s not medically 
acceptable at all and the public need to be certain of the quality of 
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products they are purchasing from overseas websites because you simply 
don’t know what you are getting (Dr Caswell, from the CPSA, in 
Smethurst, 2012: 98). 
 
There are significant risks associated with Botox and faux-tox that are heightened 
when Botox is completely reconfigured from medical to cultural artefact. Nevertheless, 
such calls cannot be separated from claims to economic, social and cultural capital, 
which are the result of Botox’s valued social position. The tensions between different 
forms of contextual Botox, including its movement away from the medical field and 
contexts, not only highlights the need to take Botox seriously but also the need to 
acknowledge and examine it as a medical and cultural artefact of great significance.  
 
Conclusion 
 
Botox has evolved into a social phenomenon that is different than most 
[injectables] (Steven Basta, Chief Executive Officer of BioForm, in Prior, 
2007: 6). 
 
As informed by the Bourdieusian concepts of field and capital, this article has explored 
how Botox has been domesticated to the point of being mundane. With much discussion 
focused on more invasive CETs, Botox has been overlooked as a significant medical 
and cultural artefact. This is well evidenced by the dearth of social research on peoples’ 
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experiences with Botox, be they good, bad, or mundane. We argue that mundane 
technologies such as Botox profoundly influence everyday life, and therefore should not 
be brushed aside in favour of more exotic and extreme CETs. Indeed, the accessibility 
and affordability of Botox facilitates a larger consumer market than surgical CETs. 
Botox is a distinct social and medical practice in its hypernormalisation and 
everydayness, and in its many fields and forms as a medical and cultural artefact. 
Significantly, we make no stance on whether individuals should pursue Botox injections 
or not, nor do we examine it within a patriarchal framework. Rather, we highlight the 
need to empirically explore the knowledges and uses that constitute and reconstitute 
Botox, including positive and negative outcomes from multiple perspectives, to better 
understand its social integration and acceptance as an artefact.  
Using Bourdieu’s concepts of field and capital, we have shown how 
intersections and competitions between different fields and the mobilisation of capital – 
be it economic, social, cultural – alters Botox as an artefact. For example, the medical 
field seeks to maintain exclusive control and ownership of Botox and its use by drawing 
on their social and cultural capital, which could enable them to maximise Botox’s 
economic capital. The political field, however, determines the regulation of Botox, and 
this opens new opportunities for the medical field as well as challenging their 
exclusivity. This creates tensions in the medical field, and allows Botox to enter other 
fields. While this entry into new fields, which we identify as beauty and domestic, 
opens and creates new markets, this is achieved only through significant risks.  The use 
of field and capital has also allowed us to explore the multiple ways in which Botox 
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may be interpreted, depending on the field and context in which it is found and 
conceptualised, and the knowledge and practices evident therein. Such an approach is 
useful for examining artefacts that are found in multiple contexts, what this means in 
relation to the use of capital, and the competition between and invested interests within 
fields. This creates the many forms of contextual Botox. 
While Botox might connect with feminist ways of thinking, and could be 
conceptualised as an oppressive apparatus or even as a playful party trick, it is also a 
bodily technology complicated by its deadliness, its historical and contemporary 
applications (including warfare), and the elaborate alignments between place, people, 
product, and knowledge. Our argument is that regardless of what configurations and 
outcomes emerge, including consumer and provider experiences, it is a technology that 
deserves serious attention because Botox is significantly different from other CETs, and 
because of its configurations and reconfigurations distinguish it from cosmetic surgery. 
Existing literature on CETs fails to account for these distinct differences, thus 
subsuming Botox into other cosmetic practices. A failure to understand the divergent 
configurations of CETs means a failure to adequately understand them as a whole and 
individually. Overlooking these differences means Botox is becoming invisible to and 
in the scholarship. The challenges that Botox’s construction as a cultural artefact poses 
to medicalisation, and the tensions between this artefact’s medical and cultural 
configurations, are undervalued. 
Due to the lack of sociological, feminist, and cultural studies attention to Botox, 
our examination has heavily relied on media reports and press releases from 
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professional bodies and the existing research on surgical CETs. This should not deter 
from the significance. There is no doubt that Botox is being marketed in ways that feed 
off the vulnerabilities of those seeking it (Parker, 2009). There is also no doubt Botox 
cannot be overlooked simply because it has not yet been the subject of extensive social 
research. Furthermore, the medical and social attention afforded to Botox emphasises 
the social currency of this product. Press releases from medical associations, and media 
reports including interviews with specialists, are important sources of information to 
understand how Botox is politicised, being discursively formed as an artefact, located in 
different contexts that create heterogeneous forms of distinctiveness, and being 
circulated in the public imagination. 
Socio-spatial organisation and how that relates to fields, people and knowledge 
production, are central to how Botox is constructed and experienced As a medical and 
cultural artefact, Botox is rewritten by the fields and contexts in which it is found and 
the interweaving of multiple factors that are not easily reducible. Contextual Botox has 
been an analytical tool for us to understand what is happening with this artefact. 
Therefore, while Botox is a medical product and a cultural phenomenon, it is also much 
more – and less – than that. It is something that should still be raising eyebrows. 
 
Notes 
1
 When Botox is not enough to address defined wrinkles and lines, injectable fillers 
(hyaluronic acids) are used. 
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2
 Despite reports of increasing numbers of men seeking Botox (Cosmetic Physicians 
Society of Australasia 2009a), most Botox consumers are women. For example, in 2013 
in the United States, women received 3,381,476 Botox procedures compared to 384,672 
for men (ASAPS, n.d [a]); a 89% difference. Furthermore, from 2003 to 2013 in the 
United States, men’s Botox procedures increased by 20% (309,063 to 384,672), while 
women’s increased by 42% (1,963,012 to 3,381,476) (ASAPS, n.d [a], n.d [l]).   
3 Our understanding of Botox as a technology is influenced by Foucault’s “technologies 
of the self”. These ‘permit individuals to effect by their own means or with the help of 
others a certain number of operations on their own bodies and souls, thoughts, conduct, 
and way of being, so as to transform themselves in order to attain a certain state of 
happiness, purity, wisdom, perfection, or immortality’ (Foucault, in Martin et al., 1988: 
18).  
4
 This may not be Botox, but proclaimed as such. The willingness of individuals to seek 
this out highlights the desperation of people to source Botox conveniently, cheaply, and 
privately but, like other forms of Botox that have been decontextualised (which we will 
examine soon), this masks the seriousness of the procedure and  product. 
5
 The same rules apply in Australia for other injectables such as hyaluronic acids and 
collagen.  
6
 In the United States and New Zealand, direct to consumer pharmaceutical advertising 
is permitted. This seen to provide important information to consumers (Mintzes et al., 
2002), but this content can be ‘misleading, inaccurate or unbalanced’ (Vitry, 2004: 4).  
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